Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.09% | 112.88% | -14.85% | -20.61% | -17.36% |
| Total Depreciation and Amortization | -4.42% | 0.15% | 0.60% | -4.51% | 1.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.76% | 40.00% | 0.00% | 20.76% | 251.55% |
| Change in Net Operating Assets | 207.37% | -263.79% | -9.88% | 365.00% | -374.57% |
| Cash from Operations | 57.18% | -28.31% | -19.21% | 19.59% | -29.35% |
| Capital Expenditure | -4.22% | -42.72% | 16.90% | 2.83% | -0.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 96.75% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -786.67% | 140.14% | -678.13% | -114.70% | 142.06% |
| Cash from Investing | -146.34% | 63.00% | 65.99% | -275.28% | 34.32% |
| Total Debt Issued | -212.68% | -78.27% | -78.11% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.79% | -34.55% | 79.07% | 16.47% | -20.00% |
| Repurchase of Common Stock | -85.92% | -60.28% | 54.76% | 93.10% | 81.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.44% | -1.55% | -1.66% | -7.35% | -6.73% |
| Other Financing Activities | 72.60% | -5.29% | -102.93% | -161.86% | -11,883.33% |
| Cash from Financing | 29.71% | -102.99% | 47.26% | -150.90% | -81.31% |
| Foreign Exchange rate Adjustments | -91.85% | -73.27% | 68.03% | 48.61% | 1,600.00% |
| Miscellaneous Cash Flow Adjustments | 0.00% | -- | -- | -- | 0.00% |
| Net Change in Cash | 201.96% | -101.04% | 87.04% | -1,367.66% | -152.85% |